Phage therapy or as a weapon against superbacteria

According to the latest issue of Nature Medicine, a British teenage girl with antibiotic-resistant infections was pulled back from the brink of death by a US-UK joint medical team using cocktail therapy consisting of three genetically modified viruses (bacteriophages). Isabel Hossawi, a 17-year-old British teenager, has a genetic disease of cystic fibrosis. By the summer of 2017, only one third of normal people had lung function. After lung transplantation, he almost died of intractable infection. After nine months of treatment at Greater Ormond Street Hospital in the United Kingdom, doctors believed that the survival rate was less than 1%. The doctor contacted Professor Graham Hartford, a molecular geneticist at the Howard Hughes Institute of Medicine at the University of Pittsburgh. They collaborated to develop a cocktail therapy using three bacteriophages that eventually miraculously rehabilitated Isabel and returned to school.
The bacteriophages used in cocktail therapy are viruses specially designed to attack and kill bacteria. Scientists selected three specific phages from more than 15,000 stored phages at the University of Pittsburgh and genetically engineered two of them to better attack bacteria. In June 2018, after safety tests, the team began injecting the mixture twice a day into Isabel's blood and smearing it on her skin. The treatment was incredibly successful. Six weeks later, Isabel's liver scan showed that the infection had basically disappeared and the skin ulceration had largely disappeared. At present, her treatment team is planning to add a fourth bacteriophage in an attempt to completely eradicate her infection. It is worth noting that the treatment of GM virus has little side effects on Isabel. Professor Hartfall said: "We didn't expect to be able to use these phages in actual treatment, which is a good result." Since Isabel's personalized treatment is not part of the clinical trial, it is not yet known how effective such treatment is for others. After all, finding the right specific bacteriophage for each patient is a huge challenge. In the future, scientists hope that it will be possible to search phage libraries automatically to identify and determine personalized treatment options. Some infectious strains, such as Staphylococcus aureus, which is a superbacteria gathered in hospitals, may be able to treat almost all cases by identifying only a few phages because all of these bacteria are genetically similar, thus improving the prospects of phage therapy as a conventional treatment.
Looking for chemical products? Let suppliers reach out to you!
2026-07-02
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Phase III Study of AstraZeneca's Innovative Therapy was Successful! A Listing Application Will be Submitted
-
FDA Breakthrough Therapy Designation for Topical Vitamin A Derivatives to Treat Inherited Skin Diseases
-
Sanofi's Sarclisa Combination Therapy has Significant Efficacy in the Treatment of Multiple Myeloma
-
FDA Approves New Oral Therapy to Delay Functional Decline of ALS by 33%
-
Maximum reduction of 81%! 22,000 down to $6,300 Large group of consumables with collective price cuts
-
Overview of China's medical device import and export trade in 2021
-
5 Billion! Strong Growth! Top 1 Sample Hospital Variety
-
Do You Know the Real Benefits of Eating Bird's Nest?
-
Polycarbonate PC turns out to have so many uses
-
Nation helping meet global demand for medical supplies
Recommend Reading
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
Moderna to Cut 10 Percent of Staff as COVID Vaccine Sales Plunge Stock Drops 4 Percent
-
Sun Pharma Halts US Expansion Amid 25 Percent Tariff Threat Net Profit Drops 20 Percent
-
Trump Pressures 17 Pharma CEOs to Match US Drug Prices with Global Lows September 29 Deadline Set
-
INEOS Inovyn Moths Methyl Chlorocarbonate Production Facility in Tavaux, France
-
This week, the coke market in China mainly maintained a stable operation (9.21-9.28)
-
This week, the overall trend of 180CST fuel oil in China has risen
-
Acesulfame Potassium: Safety, Side Effects, and Food Uses
-
Following Cost Fluctuations, Polyester Staple Fiber Prices Stop Falling and Rebound